Abstract:BACKGROUND: The role of programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) in persistent HBV infection is controversial. Increasing PD-1 and PD-L1 expression has been found in hepatitis B patients during immune clearance phase, but not in HBV-tolerant patients. We investigated PD-1 and PD-L1 expression and inflammation in chronic hepatitis B.METHODS: Twenty patients with chronic hepatitis B participated in this study. Fifteen patients were in the immune clearance phase, and 5 were in the immune inactive phase. Circulating HBV-specific T cells were analyzed by flow cytometric detection of major histocompatibility complex (MHC) class I peptide complexes, known as pentamers. Intra-hepatic PD-1 and PD-L1 expressions were analyzed by immunostaining.RESULTS: The frequency of pentamers, including core 18-27 (1.88%+/- 0.36%), env 335-343 (1.85%+/- 0.37%), and pol 575-583 (1.56%+/- 0.29%) was 8.30-, 7.71- and 8.48-fold greater during immune clearance phase than those during the immune inactive phase. In addition, more than 70% of circulating pentamers were PD-1 positive. During immune clearance phase, the numbers of intra-hepatic PD-1 and PD-L1 positive cells were 108 +/- 23/HPF and 97 +/- 20/HPF respectively, in contrast, there was a paucity of PD-1 and PD-L1 positive cells in the immune inactive phase. The numbers of intra-hepatic PD-1 and PD-L1 positive cells were positively correlated with serum alanine aminotransferase and the number of intra-hepatic CD8(+) T cells. Immunofluorescence showed that almost all of the intrahepatic CD8(+) T cells were PD-1 and CCR6 positive. These cells aggregated around macrophage inflammatory protein-3 alpha (MIP3 alpha) positive cells and mixed with PD-L1 positive cells.CONCLUSIONS: PD-1 and PD-L1 expressions were significantly correlated with inflammation. CCR6 and PD-1 co-expressed in the same cells; these cells were increased both in circulation and the inflamed liver and aggregated around MIP3a positive cells. The mixture of CCR6 and PD-1, MIP3a and PD-L1 positive cells created immune response compartments which played an important role in specific immune response in HBV immune clearance.

Differential Regulation Of T And B Lymphocytes By Pd-1 And Socs-1 Signaling In Hepatitis C Virus-Associated Non-Hodgkin'S Lymphoma

Programmed Death-1 Affects Suppressor of Cytokine Signaling-1 Expression in T Cells During Hepatitis C Infection.

T Cell Dysfunction by Hepatitis C Virus Core Protein Involves PD-1/PDL-1 Signaling.

PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection

Follicular Helper T Cell Exhaustion Induced by PD-L1 Expression in Hepatocellular Carcinoma Results in Impaired Cytokine Expression and B Cell Help, and is Associated with Advanced Tumor Stages.

Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4+ T cell responses

Increased PD-L1 Expression and PD-L1/CD86 Ratio on Dendritic Cells Were Associated with Impaired Dendritic Cells Function in HCV Infection.

Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14 Monocytes and CD19 B Cells with the Progression of Hepatitis B Virus Infection.

PD-1 Expression is Elevated in Monocytes from Hepatocellular Carcinoma Patients and Contributes to CD8 T Cell Suppression

Supplementary Figure S1 - S10 from PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression

PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.

PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

Characteristics and PD-1 Expression of Peripheral CD4+CD127loCD25hiFoxP3+ Treg Cells in Chronic HCV Infected-Patients

Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Regulate T-Cell Differentiation And Function Via The Signal Transducer And Activator Of Transcription 3 Pathway

CD19+CD24hiCD38hi Regulatory B Cells: a Potential Immune Predictive Marker of Severity and Therapeutic Responsiveness of Hepatitis C.

Data from PD-1<sup>hi</sup> Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression

Aberrant Production of Soluble Inducible T Cell Co-Stimulator and Soluble Programmed Cell Death Protein 1 in Patients with Chronic Hepatitis B

Effect of Regulatory B Cell Expansion on Tissue-Resident TPH Cells Immune Evasion in Hepatocellular Carcinoma.

Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy

Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection

Programmed Death 1 and Programmed Death Ligand 1 Expressions in Patients with Chronic Hepatitis B